Purple Biotech Ltd.

Regulatory Filings • Aug 14, 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d false

����� ����� ��"�	2 380
KITOV PHARMA LTD
Corporation no: 520031238	10994
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	13/08/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-084205	Time of broadcast: 23:59 23:47:05

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2019 Commission File Number: 001-37643 KITOV PHARMA LTD. On August 13, 2019, the Administrative Enforcement Committee of the Israel Securities Authority approved an administrative enforcement agreement, entered into by and amongst ISA, the Company and certain officers, pursuant to which the Company and each of the officers settled the ISA�s claims that under Israeli Securities Laws the Company made negligent disclosures in a number of its historical reports filed with the ISA in 2014 and 2015, and the ISA decided to discontinue its criminal investigation and to cease all proceedings against the Company and its principals.

f6k081319b_kitovpharmaEDGAR5_Bannerless_isa.pdf

���� ���� ����� ����� �� ����� ������� ����� �� ����� ����� ������ ��� ����� ������� ������
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2017-02-014070     2017-02-014778     2017-02-044658
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 06/08/2019
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: info@kitovpharma.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: avraham@kitovpharma.com 1
Israel